Browsing Category
Pharmaceuticals
Venus Remedies Receives Second PLI Incentive Disbursement, Reinforcing Manufacturing…
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the world’s leading fixed-dosage injectable manufacturers, has received its second incentive disbursement under the Government of…
FIRST GENERIC APPROVAL: VENUS REMEDIES SECURES MARKETING AUTHORISATION FOR…
Bengaluru: Venus Remedies Limited among the world’s leading fixed-dosage injectable manufacturers, has secured the marketing authorization from the Indonesian regulatory authority for its…
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Bosutinib…
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its supplemental Abbreviated New…
Govt bans manufacturing, sale and distribution of oral drug Nimesulide above 100 mg
New Delhi: The government has prohibited the manufacturing, sale and distribution of all oral formulations containing Nimesulide above 100 mg with immediate effect. Ministry of Health and…
Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine…
Bengaluru: Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India Limited, has received Tentative Approval (TA) from the U.S. Food and Drug Administration (FDA) for its…
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost…
December: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug…
Top 5 Brands Powering the Growth of India’s Pharma Industry
As India’s pharmaceutical sector continues its rapid evolution, driven by digital transformation, regulatory complexity, global expansion, and heightened focus on data integrity,…
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Loteprednol…
December: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug…
Sun Pharma concludes SUN PRISM 2025, a National B-school Competition
MUMBAI: Sun Pharmaceutical Industries Limited (Sun Pharma), India’s No. 1 pharmaceutical company by revenues and prescriptions1, concluded the grand finale of SUN PRISM 2025, its flagship…
Mankind Pharma expands PetStar portfolio with launch of PetStar Delight cat food…
Bengaluru: Mankind Pharma, one of India's leading pharmaceutical companies, today announced the launch of PetStar Delight, expanding its PetStar brand into the cat food segment. The new…